Hyper Corporation

Hyper Corporation Interest Expense

The Interest Expense of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is -28.42 B KRW. In the previous year, Interest Expense was -634.74 M KRW — a change of 4,377.63% (lower).

Interest Expense

-28.42 BKRW

YoY

4,377.63%

Last updated:

Interest Expense of Hyper Corporation is 2024 -28.42 B KRW. Interest Expense of Hyper Corporation was 2023 -634.74 M KRW. It decreases by 4,377.63% lower compared to the previous year.

The Hyper Corporation Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
39.00 M KRW
Jan 1, 2018
240.00 M KRW
Jan 1, 2019
240.00 M KRW
Jan 1, 2020
-1.82 B KRW
Jan 1, 2021
-1.21 B KRW
Jan 1, 2022
969.23 M KRW
Jan 1, 2023
-634.74 M KRW
Jan 1, 2024
-28.42 B KRW
The Hyper Corporation Interest Expense history
YEARInterest ExpenseYoY
-28.42 BKRW+4,377.63%
-634.74 MKRW-165.49%
969.23 MKRW-180.32%
-1.21 BKRW-33.51%
-1.82 BKRW-856.25%
240.00 MKRW0.00%
240.00 MKRW+515.38%
39.00 MKRW-110.60%
-368.00 MKRW-27.27%
-506.00 MKRW-855.22%
67.00 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Interest Expense of Hyper Corporation is -28.42 B KRW in 2024.

Interest Expense of Hyper Corporation changed from -634.74 M KRW to -28.42 B KRW, representing a 4,377.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Hyper Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hyper Corporation

All Key Metrics — Hyper Corporation